CLINICAL_TRIALS
trial_result
· 2018-09-20
Clinical Trial Update: A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Summary
Phase 2 study evaluating lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Leukemia, Myeloid | Phase 2 | Status: COMPLETED | Results posted: 2018-09-20